[1] CHRISTOPHER MILLER. Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle[J]. Nature, 1985, 313 6000: 316-318. DOI:
10.1038/313316a0[2] G GIMENEZ-GALLEGO. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1988, 85 10: 3329-3333. DOI:
10.1073/pnas.85.10.3329[3] S GRISSMER. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.[J]. Molecular Pharmacology, 1994, 45 6: 1227-1234.
[4] OSCAR SÁNCHEZ-CARRANZA . Pharmacology of hSlo3 channels and their contribution in the capacitation-associated hyperpolarization of human sperm[J]. Biochemical and biophysical research communications, 2015, 466 3: Pages 554-559. DOI:
10.1016/j.bbrc.2015.09.073[5] N J LOGSDON. A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes.[J]. The Journal of Biological Chemistry, 1997, 272 52: 32723-32726. DOI:
10.1074/jbc.272.52.32723